share_log

SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference

SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference

SEQLL 將出席 HC 溫賴特 24 年度全球會議
GlobeNewswire ·  2022/09/06 20:05

BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will present a corporate overview and be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Conference taking place from September 12-14, 2022.

麻薩諸塞州比勒里卡,2022 年 9 月 6 日(全球美通社)-Seqll Inc.(「SEQLL」或「公司」)(納斯達克:SQL; SQLLW),為合作夥伴提供生命科學儀器和研究服務的技術公司,今天宣布,SEQLL 的首席執行官丹尼爾·瓊斯將在 H.1 虛擬會議上提供一個公司概述並可用於即將舉行的 1xC Wain1 虛擬會議。24 年度全球會議將於 2022 年 9 月 12 日至 14 日舉行。

The presentation will be available on demand beginning at 7:00 am ET on Monday, September 12th. To view the presentation or request a 1x1 meeting, click HERE to register and attend the event.

該演示文稿將在美國東部時間 9 月 12 日星期一上午 7:00 開始按需提供。要查看演示文稿或請求 1x1 會議,請單擊此處註冊並參加活動。

About SeqLL Inc.
SeqLL Inc. ("SeqLL") is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple "omics" fields. The Company leverages its expertise with its True Single Molecule Sequencing ("tSMS®") platform to empower scientists and researchers with improved genetic tools to better understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with today's precision medicine. In sum, our experienced team works with our collaborators to develop innovative solutions tailored to the needs of each specific project.

關於 SEQLL
SeQll Inc.(「SEQLL」)是一家提供生命科學儀器和研究服務的技術公司,旨在開發跨多個「組學」領域的新穎科學資產和智慧財產權的合作夥伴關係。該公司利用其專業知識及其真正的單分子測序 (「TSM®」) 平台,為科學家和研究人員提供改進的基因工具,以更好地了解疾病的分子機制,這對基因組醫學新突破的持續發展至關重要,並希望解決當今精準醫學所涉及的關鍵問題。總而言之,我們經驗豐富的團隊與我們的合作者合作,根據每個特定項目的需求開發創新的解決方案。

Contacts:
Ashley R. Robinson
LifeSci Advisors, LLC
Tel: +1 (617) 430-7577
Email: arr@lifesciadvisors.com

聯絡人:
阿什利·罗宾逊
生活顧問有限責任公司
電話:1 (617)
電郵地址:arr@lifesciadvisors.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論